NO991823L - Substituerte tricykliske forbindelser - Google Patents

Substituerte tricykliske forbindelser

Info

Publication number
NO991823L
NO991823L NO991823A NO991823A NO991823L NO 991823 L NO991823 L NO 991823L NO 991823 A NO991823 A NO 991823A NO 991823 A NO991823 A NO 991823A NO 991823 L NO991823 L NO 991823L
Authority
NO
Norway
Prior art keywords
tricyclic compounds
substituted tricyclic
substituted
compounds
tricyclic
Prior art date
Application number
NO991823A
Other languages
English (en)
Norwegian (no)
Other versions
NO991823D0 (no
Inventor
Nicholas James Bach
Jolie Anne Bastian
Douglas Wade Beight
Michael Dean Kinnick
Michael John Martinelli
Edward David Mihelich
John Michael Morin Jr
Daniel Jon Sall
Jason Scott Sawyer
Edward C R Smith
Tulio Suarez
Qiuping Wang
Thomas Michael Wilson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO991823D0 publication Critical patent/NO991823D0/no
Publication of NO991823L publication Critical patent/NO991823L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
NO991823A 1998-04-17 1999-04-16 Substituerte tricykliske forbindelser NO991823L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6216598A 1998-04-17 1998-04-17

Publications (2)

Publication Number Publication Date
NO991823D0 NO991823D0 (no) 1999-04-16
NO991823L true NO991823L (no) 1999-10-18

Family

ID=22040624

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991823A NO991823L (no) 1998-04-17 1999-04-16 Substituerte tricykliske forbindelser

Country Status (27)

Country Link
EP (2) EP0950661B1 (de)
JP (1) JP4435325B2 (de)
KR (1) KR19990083234A (de)
CN (1) CN1235968A (de)
AR (1) AR018185A1 (de)
AT (2) ATE259818T1 (de)
AU (1) AU757454B2 (de)
BR (1) BR9901275A (de)
CA (1) CA2269256A1 (de)
CO (1) CO5080728A1 (de)
CZ (1) CZ137199A3 (de)
DE (2) DE69912670T2 (de)
EA (1) EA003129B1 (de)
ES (2) ES2213668T3 (de)
HU (1) HUP9901219A1 (de)
ID (1) ID23219A (de)
IL (1) IL129484A0 (de)
NO (1) NO991823L (de)
NZ (1) NZ335252A (de)
PE (1) PE20000472A1 (de)
PL (1) PL332564A1 (de)
SG (1) SG106035A1 (de)
SV (1) SV1999000052A (de)
TR (1) TR199900842A2 (de)
TW (1) TW555760B (de)
YU (1) YU19099A (de)
ZA (1) ZA992773B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513555A (ja) * 1997-08-28 2001-09-04 イーライ・リリー・アンド・カンパニー 非リウマチ様関節炎の処置方法
AU2001244635A1 (en) * 2000-03-30 2001-10-15 Yamanouchi Pharmaceutical Co..Ltd. Hydrazide derivatives
CN1450893A (zh) * 2000-07-14 2003-10-22 伊莱利利公司 治疗脓毒症的方法
ES2264708T3 (es) * 2000-12-18 2007-01-16 Eli Lilly And Company Derivados tetraciclicos como inhibidores de la spla2.
JP2004525154A (ja) * 2001-03-28 2004-08-19 イーライ・リリー・アンド・カンパニー ｓＰＬＡ２インヒビターとしての置換カルバゾール
US7160909B2 (en) 2001-08-09 2007-01-09 Eli Lilly And Company Cyclopenta[b]indole derivatives as sPLA2 inhibitors
ATE312817T1 (de) 2001-08-09 2005-12-15 Lilly Co Eli Cyclohept'bö indolderivate als spla2-inhibitoren
US6992100B2 (en) 2001-12-06 2006-01-31 Eli Lilly And Company sPLA2 inhibitors
MX2007005199A (es) 2004-11-01 2007-05-11 Wyeth Corp Indolizinas sustituidas y derivados como agentes del sistema nervioso central.
KR101614723B1 (ko) 2008-01-11 2016-04-22 알바니 몰레큘라 리써치, 인크. Ｍｃｈ 길항물질로서 (1-아지논)-치환된 피리도인돌
US9073925B2 (en) 2009-07-01 2015-07-07 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
US8993765B2 (en) 2010-12-21 2015-03-31 Albany Molecular Research, Inc. Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
DK2697223T3 (en) * 2011-04-14 2016-09-05 Actelion Pharmaceuticals Ltd 7- (heteroaryl-amino) -6,7,8,9-tetrahydro-pyrido [1,2-a] indole-acetic acid derivatives and their use as prostaglandin D2 receptor
CN104203951B (zh) 2012-03-16 2016-11-02 生命医药公司 肝x受体调节剂
WO2013138568A1 (en) 2012-03-16 2013-09-19 Vitae Pharmaceuticals, Inc. Liver x reception modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3979391A (en) * 1972-11-22 1976-09-07 Sterling Drug Inc. 1,2,3,4-Tetrahydrocarbazoles
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
JPH10505584A (ja) * 1994-07-21 1998-06-02 イーライ・リリー・アンド・カンパニー インドリジンｓＰＬＡ▲下２▼インヒビター
AU1289797A (en) * 1995-12-13 1997-07-03 Eli Lilly And Company Naphthyl acetamides as spla2 inhibitors
JP2001503055A (ja) * 1996-10-30 2001-03-06 イーライ・リリー・アンド・カンパニー 置換三環化合物群
AU9664198A (en) * 1997-09-26 1999-04-23 Eli Lilly And Company Method for the treatment of cystic fibrosis
CA2310250A1 (en) * 1997-11-14 1999-05-27 August Masaru Watanabe Treatment for alzheimer's disease

Also Published As

Publication number Publication date
ES2210979T3 (es) 2004-07-01
AR018185A1 (es) 2001-10-31
NO991823D0 (no) 1999-04-16
EA003129B1 (ru) 2003-02-27
YU19099A (sh) 2001-09-28
HUP9901219A1 (hu) 2000-08-28
CN1235968A (zh) 1999-11-24
ATE254128T1 (de) 2003-11-15
HU9901219D0 (en) 1999-06-28
EP0950661A1 (de) 1999-10-20
PL332564A1 (en) 1999-10-25
SV1999000052A (es) 2000-03-14
AU757454B2 (en) 2003-02-20
EA199900304A2 (ru) 1999-10-28
ATE259818T1 (de) 2004-03-15
PE20000472A1 (es) 2000-06-02
EP1156050B1 (de) 2004-02-18
EP1156050A3 (de) 2001-11-28
KR19990083234A (ko) 1999-11-25
CO5080728A1 (es) 2001-09-25
TR199900842A2 (xx) 2000-09-21
DE69914951D1 (de) 2004-03-25
AU2381899A (en) 1999-10-28
CA2269256A1 (en) 1999-10-17
EP0950661B1 (de) 2003-11-12
TW555760B (en) 2003-10-01
ES2213668T3 (es) 2004-09-01
IL129484A0 (en) 2000-02-29
EP1156050A2 (de) 2001-11-21
DE69914951T2 (de) 2004-12-23
ZA992773B (en) 2002-07-16
NZ335252A (en) 2000-11-24
BR9901275A (pt) 2000-05-02
JPH11322745A (ja) 1999-11-24
SG106035A1 (en) 2004-09-30
DE69912670T2 (de) 2004-08-12
ID23219A (id) 2000-03-30
EA199900304A3 (ru) 2000-04-24
JP4435325B2 (ja) 2010-03-17
DE69912670D1 (de) 2003-12-18
CZ137199A3 (cs) 1999-11-17

Similar Documents

Publication Publication Date Title
NO991821L (no) Substituerte tricykliske forbindelser
NO20003706L (no) Ny tricyklisk forbindelse
LTC1124961I2 (lt) Trombopoetino junginiai
ATE229954T1 (de) Betacarbolinverbindungen
ID28266A (id) Senyawa-senyawa amidin
ID30132A (id) Turunan-turunan pirazol trisiklik
NO20004299D0 (no) Organiske forbindelser
NO20011745L (no) Forbindelser
FI4209U1 (fi) Uusia yhdisteitä
DK0839806T3 (da) Substituerede tricykliske forbindelser
ID27004A (id) Senyawa-senyawa kalsilitik
LV12207A (lv) Tricikliski savienojumi
NO991823L (no) Substituerte tricykliske forbindelser
NO20006662L (no) Fluorfenylresin-forbindelser
EP1105133A4 (de) Tricyclische verbindungen
SE9802981D0 (sv) New tetracyclic compounds
IDP000021799A (id) Senyawa-senyawa pirolum tersubstitusi
IDP000021790A (id) Senyawa-senyawa pirolum tersubstitusi
SE9803669D0 (sv) Novel compounds
SE9801989D0 (sv) Novel compounds
SE9800458D0 (sv) Novel compounds
SE9804211D0 (sv) Novel compounds
SE9804493D0 (sv) Novel compounds
SE9804494D0 (sv) Novel compounds
SE9801397D0 (sv) Novel compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application